Aerosol delivery systems for bronchial asthma.-Reference-Cited by-同舟云学术

Aerosol delivery systems for bronchial asthma.

Published:1996-03-01 Issue:845 Volume:72 Page:151-156
ISSN:0032-5473
Container-title:Postgraduate Medical Journal
language:en
Short-container-title:Postgraduate Medical Journal

Author:

Ariyananda P. L.,Agnew J. E.,Clarke S. W.

Publisher

BMJ

Subject

General Medicine

Reference57 articles.

1. Inhalation devices and techniques;Newman, S.P.; Clarke, S.W.,1992

2. Medihaler therapy for bronchial asthma: a new type of aerosol therapy;Freedman, T.;Postgrad Med,1956

3. Neural mechanisms in asthma;Barnes, P.J.;Br Med Bull,1992

4. Pressurised aerosol deposition in the human lung with and without an 'open' spacer device;Newman, S.P.; Clark, A.R.; Talaee, N.; Clarke, S.W.;Thorax,1989

5. Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler;Newman, S.P.; Moren, F.; Trofast, E.; Talaee, N.; Clarke, S.W.;Eur RespirJ,1989

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pulmonary administration route: Advantages and challenges;A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy;2021

2. Scope and limitations on aerosol drug delivery for the treatment of infectious respiratory diseases;Journal of Controlled Release;2020-09

3. Inhaled nanoparticles–An updated review;International Journal of Pharmaceutics;2020-09

4. Characterization of a new aerosol antibiotic/adjuvant combination for the treatment of P. aeruginosa lung infections;International Journal of Pharmaceutics;2020-08

5. Drug delivery system in pulmonary disease: Role of microparticles;Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems;2020